Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia

Am J Hematol. 2024 Apr;99(4):759-762. doi: 10.1002/ajh.27232. Epub 2024 Feb 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Chronic Disease
  • Drug Resistance, Neoplasm / genetics
  • Fusion Proteins, bcr-abl / genetics
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
  • Leukemia, Myeloid*
  • Mutation
  • Protein Kinase Inhibitors / pharmacology

Substances

  • Fusion Proteins, bcr-abl
  • Protein Kinase Inhibitors